In early-stage cervical cancer, high IL-17 expression was identified as an independent prognostic factor for poor outcomes (29), as IL-17 promotes cervical cancer cell proliferation and enhances intercellular adhesion. This evidence concerns the gene IL17A and cervical cancer.